Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Actis acquires 90% of 800 Super as Southeast Asia deployment reaches $1.7bn
Actis acquires 90% of 800 Super as Southeast Asia deployment reaches $1.7bn Actis has completed the acquisition of a 90% stake in Singapore-based environmental management company 800 Super. The investment was made through Actis’ Long Life Infrastructure Fund 2 and...
Lead Edge lands $3.5bn for seventh fund focused on software deals
Lead Edge lands $3.5bn for seventh fund focused on software deals Lead Edge Capital has raised $3.5bn for its seventh fund, as the growth equity firm doubles down on software investments despite volatility linked to artificial intelligence, according to a report by...
Apollo acquires 37% stake in €1.75bn Syntegon alongside CVC to drive next growth phase
Apollo acquires 37% stake in €1.75bn Syntegon alongside CVC to drive next growth phase Apollo-managed funds have agreed to acquire a 37% minority stake in Syntegon from CVC Capital Partners, as the private equity firms partner to accelerate the company’s next phase of...